SGLT2 inhibitors and reduced risk of Parkinson’s disease and dementia: Journal club
Impossibile aggiungere al carrello
Rimozione dalla Lista desideri non riuscita.
Non è stato possibile aggiungere il titolo alla Libreria
Non è stato possibile seguire il Podcast
Esecuzione del comando Non seguire più non riuscita
SGLT2 inhibitors and reduced risk of Parkinson’s disease and dementia: Journal club
-
Letto da:
-
Di:
A proposito di questo titolo
This episode continues our run of journal club episodes, this time looking at whether SGLT2 inhibitors used for type 2 diabetes mellitus have any associated reduction in dementia (such as Alzheimer’s disease and vascular dementia) and Parkinson’s disease, therefore falling into these respective series as well. The content of this episode is best suited for more senior audience members (neurologists and neurology trainees), although all audience members (including medical students) will derive benefit from the way it teaches how to dissect a journal article, demonstrating the process involved in this critical evaluation and ultimately teaching how to decide in what ways a journal article applies to your daily clinical practice.#medicaleducation #diabetes #parkinsonsdisease #dementia #neurology #rneurologyeducation